University of Maryland School of Medicine

Top Virologists to Meet in Monaco to Tackle Ongoing Pandemic Challenges and Emerging Viral Threats

Retrieved on: 
Wednesday, October 11, 2023

This coalition of the world’s leading medical virology researchers, who work together to prevent illness and death from viral disease, will hold high-level scientific sessions examining pandemic preparedness and current threats.

Key Points: 
  • This coalition of the world’s leading medical virology researchers, who work together to prevent illness and death from viral disease, will hold high-level scientific sessions examining pandemic preparedness and current threats.
  • A special GVN-CSM joint session will focus specifically on preparedness in European Union countries and will be attended by the High Patronage of H.S.H.
  • Prince Albert II of Monaco, among other dignitaries.
  • Lander Professor of Public Health, Yale School of Public Health as its next GVN President, effective November 1, 2023.

New Data from Phase 3 Trial Further Validate Prognostic Value of Veracyte’s Decipher Prostate Genomic Classifier

Retrieved on: 
Wednesday, October 4, 2023

(Nasdaq: VCYT) today announced that new data from a large, randomized phase 3 trial reinforce the value of the Decipher Prostate Genomic Classifier in helping physicians make more informed treatment decisions for their patients with prostate cancer.

Key Points: 
  • (Nasdaq: VCYT) today announced that new data from a large, randomized phase 3 trial reinforce the value of the Decipher Prostate Genomic Classifier in helping physicians make more informed treatment decisions for their patients with prostate cancer.
  • Data from a second study presented at ASTRO 2023 reveal there is minimal to moderate risk-score correlation between the gene expression signatures of three commercially available genomic classifiers, including the Decipher Prostate test.
  • Researchers generated Decipher Prostate test scores using biopsy samples from 183 patients, who were followed for a median of 9.9 years.
  • Additionally, patients with higher-risk Decipher Prostate genomic scores had worse DM (sHR 2.82, 95% CI) compared to those with lower-risk scores.

Dr. Toba N. Niazi Appointed Chief of the Section of Neurosurgery and Co-Director of Nicklaus Children's Brain Institute

Retrieved on: 
Wednesday, October 4, 2023

MIAMI, Oct. 4, 2023 /PRNewswire/ -- Dr. Toba N. Niazi has been appointed Chief of the Section of Neurosurgery for Nicklaus Children's Pediatric Specialists (NCPS) and assumes a leadership position within the Nicklaus Children's Brain Institute as Director of the hospital's Division of Neurosurgery. She will lead the Brain Institute in collaboration with Dr. Paula Schleifer, Director of the Division of Neurology. 

Key Points: 
  • MIAMI, Oct. 4, 2023 /PRNewswire/ -- Dr. Toba N. Niazi has been appointed Chief of the Section of Neurosurgery for Nicklaus Children's Pediatric Specialists (NCPS) and assumes a leadership position within the Nicklaus Children's Brain Institute as Director of the hospital's Division of Neurosurgery.
  • She will lead the Brain Institute in collaboration with Dr. Paula Schleifer, Director of the Division of Neurology.
  • "We honor Dr. Ragheb for his years of leadership and contributions to the Brain Institute and welcome Dr. Niazi to her new role.
  • The national accolades earned by the Nicklaus Children's Brain Institute reaffirms that Nicklaus Children's is the hospital where children matter most.

Groundbreaking Study Finds Natural Formulation by MDbio – The Doctors BrandTM Significantly Improves Sleep, Anxiety, Stress, and Overall Well-being

Retrieved on: 
Tuesday, October 3, 2023

Los Angeles, CA, Oct. 03, 2023 (GLOBE NEWSWIRE) -- In a momentous large-scale clinical trial, a MDSleep formulation by MDbio – The Doctors BrandTM was proven to significantly improve sleep compared to placebo.

Key Points: 
  • Los Angeles, CA, Oct. 03, 2023 (GLOBE NEWSWIRE) -- In a momentous large-scale clinical trial, a MDSleep formulation by MDbio – The Doctors BrandTM was proven to significantly improve sleep compared to placebo.
  • Results showed the formulation enhanced sleep onset, and supported restful and healthy sleep.
  • Furthermore, the product led to significant improvements in feelings of anxiety, stress, and well-being compared to placebo.
  • This study was one of history’s largest double-blind randomized placebo controlled trials to demonstrate effectiveness of a non-melatonin supplement for improving sleep.

Eledon Pharmaceuticals Announces Use of Tegoprubart anti-CD40L Antibody in Second-ever Transplant of Genetically Modified Heart from a Pig to a Human

Retrieved on: 
Monday, September 25, 2023

IRVINE, Calif., Sept. 25, 2023 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN) today announced that tegoprubart, the company’s investigational anti-CD40 antibody, was used as a cornerstone component of the chronic immunosuppressive regimen administered following the second-ever transplant of a genetically modified heart from a pig to a human. The procedure was completed on September 20th at University of Maryland Medical Center on a 58-year-old male suffering from heart failure.

Key Points: 
  • IRVINE, Calif., Sept. 25, 2023 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN) today announced that tegoprubart, the company’s investigational anti-CD40 antibody, was used as a cornerstone component of the chronic immunosuppressive regimen administered following the second-ever transplant of a genetically modified heart from a pig to a human.
  • The procedure was completed on September 20th at University of Maryland Medical Center on a 58-year-old male suffering from heart failure.
  • “The historic procedure we conducted on our courageous patient brings us to a pivotal moment in the history of organ transplantation.
  • Strategies to better and more safely protect transplanted organs and thus increase how long they function represent a significant area of unmet need in organ transplantation.

Patient Engagement Solutions Market, 2035 - ResearchAndMarkets.com

Retrieved on: 
Friday, September 22, 2023

The COVID-19 pandemic has accelerated the adoption of patient experience solutions and telehealth, driving the growth of the patient engagement solutions market.

Key Points: 
  • The COVID-19 pandemic has accelerated the adoption of patient experience solutions and telehealth, driving the growth of the patient engagement solutions market.
  • Considering the advantages offered by patient engagement solutions and growing demand for virtual healthcare across the world, specifically post the COVID-19 pandemic, companies have started implementing different patient engagement strategies that are anticipated to drive market growth during the forecast period.
  • Implementation of ChatGPT is emerging as one of the key patient engagement strategies being adopted by patient engagement service providers.
  • This transformative synergy between ChatGPT and patient engagement solutions is likely to position providers as industry leaders, offering comprehensive and innovative solutions for improved patient outcomes and enhanced healthcare experience.

INTERNATIONALLY RENOWNED DERMATOLOGIST AND PHYSICIAN SCIENTIST SHAWN KWATRA, MD, NAMED NEW CHAIR OF DERMATOLOGY AT THE UM SCHOOL OF MEDICINE AND CHIEF OF SERVICE OF DERMATOLOGY AT UM MEDICAL CENTER

Retrieved on: 
Monday, September 18, 2023

Dr. Kwatra, who will begin the new role in early 2024, will hold the Joseph W. Burnett Endowed Professor and Chair in Dermatology.

Key Points: 
  • Dr. Kwatra, who will begin the new role in early 2024, will hold the Joseph W. Burnett Endowed Professor and Chair in Dermatology.
  • Dr. Kwatra joins UMSOM from Johns Hopkins University School of Medicine, where he served as the Founding Director of the Johns Hopkins Itch Center.
  • "It is an honor to be the next Chair of Dermatology at such a prestigious medical school," said Kwatra.
  • He earned his undergraduate degree from Duke University and his medical degree from Wake Forest University School of Medicine.

Global Patient Engagement Solutions Market Analysis Report 2023-2035: Solution Providers Set to Transform Healthcare as Big Players Strengthen Their Presence

Retrieved on: 
Thursday, September 14, 2023

The COVID-19 pandemic has accelerated the adoption of patient experience solutions and telehealth, driving the growth of the patient engagement solutions market.

Key Points: 
  • The COVID-19 pandemic has accelerated the adoption of patient experience solutions and telehealth, driving the growth of the patient engagement solutions market.
  • A brief introduction to important concepts related to patient engagement solutions, featuring information on various types of patient engagement solutions and their applications.
  • Elaborate profiles of prominent players (shortlisted based on our proprietary company competitiveness analysis) offering patient engagement solutions.
  • A detailed market forecast analysis in order to estimate the existing market size and future opportunity for patient engagement solution providers over the next decade.

Mercy Continues to Expand with New Personal Physicians site in Hunt Valley

Retrieved on: 
Tuesday, July 25, 2023

BALTIMORE, July 24, 2023 /PRNewswire-PRWeb/ -- As part of Mercy Health Services' ongoing efforts to expand the reach of the 149-year Sisters of Mercy tradition of quality health care, Mercy has officially opened Mercy Personal Physicians at Hunt Valley.

Key Points: 
  • As part of Mercy Health Services' ongoing efforts to expand the reach of the 149-year Sisters of Mercy tradition of quality health care, Mercy has officially opened Mercy Personal Physicians at Hunt Valley .
  • BALTIMORE, July 24, 2023 /PRNewswire-PRWeb/ -- As part of Mercy Health Services' ongoing efforts to expand the reach of the 149-year Sisters of Mercy tradition of quality health care, Mercy has officially opened Mercy Personal Physicians at Hunt Valley .
  • "Mercy Personal Physicians at Hunt Valley is the latest addition to Mercy's efforts to 'ring the beltway' with community health centers," Dr. Lowe said.
  • Editor's Note: Maryland Family Care is the medical group practice which employs primary care physicians in the Mercy Personal Physicians network.

Roche to showcase next-generation diagnostic solutions at the American Association of Clinical Chemistry 2023 Clinical Lab Expo

Retrieved on: 
Wednesday, July 19, 2023

The Roche exhibit booth and Roche Idea Lab series featuring industry experts will highlight how our commitments to science, operational simplicity and partnership can improve patient care.

Key Points: 
  • The Roche exhibit booth and Roche Idea Lab series featuring industry experts will highlight how our commitments to science, operational simplicity and partnership can improve patient care.
  • INDIANAPOLIS and ANAHEIM, Calif., July 19, 2023 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) will showcase a science-driven and patient-centric exhibit at the 2023 American Association of Clinical Chemistry (AACC) Scientific Meeting and Clinical Lab Expo, July 23-27 in Anaheim, California.
  • These systems can provide healthcare communities with the future benefit of an extended diagnostic platform offering clinical chemistry, molecular diagnostics, immunoassays and mass spectrometry.
  • For more information about Roche's participation at AACC 2023 and Roche Idea Lab programming, visit AACC.roche.com .